Literature DB >> 35857259

The Progress of Stem Cell Therapy in Myocardial-Infarcted Heart Regeneration: Cell Sheet Technology.

Raissa Munderere1,2, Seon-Hwa Kim1,2, Changsu Kim3, Sang-Hyug Park4,5,6.   

Abstract

Various tissues, including the heart, cornea, bone, esophagus, bladder and liver, have been vascularized using the cell sheet technique. It overcomes the limitations of existing techniques by allowing small layers of the cell sheet to generate capillaries on their own, and it can also be used to vascularize tissue-engineered transplants. Cell sheets eliminate the need for traditional tissue engineering procedures such as isolated cell injections and scaffold-based technologies, which have limited applicability. While cell sheet engineering can eliminate many of the drawbacks, there are still a few challenges that need to be addressed. The number of cell sheets that can be layered without triggering core ischemia or hypoxia is limited. Even when scaffold-based technologies are disregarded, strategies to tackle this problem remain a substantial impediment to the efficient regeneration of thick, living three-dimensional cell sheets. In this review, we summarize the cell sheet technology in myocardial infarcted tissue regeneration.
© 2022. Korean Tissue Engineering and Regenerative Medicine Society.

Entities:  

Keywords:  Cell sheet; Myocardial infarction; Regenerative medicine; Stem cells

Mesh:

Year:  2022        PMID: 35857259      PMCID: PMC9478006          DOI: 10.1007/s13770-022-00467-z

Source DB:  PubMed          Journal:  Tissue Eng Regen Med        ISSN: 1738-2696            Impact factor:   4.451


  155 in total

1.  Electroactive monolayer substrates that selectively release adherent cells.

Authors:  W S Yeo; C D Hodneland; M Mrksich
Journal:  Chembiochem       Date:  2001-08-03       Impact factor: 3.164

2.  Impaired myocardium regeneration with skeletal cell sheets--a preclinical trial for tissue-engineered regeneration therapy.

Authors:  Shigeru Miyagawa; Atsuhiro Saito; Taichi Sakaguchi; Yasushi Yoshikawa; Takashi Yamauchi; Yukiko Imanishi; Naomasa Kawaguchi; Noboru Teramoto; Nariaki Matsuura; Hidehiro Iida; Tatsuya Shimizu; Teruo Okano; Yoshiki Sawa
Journal:  Transplantation       Date:  2010-08-27       Impact factor: 4.939

3.  Clinical outcome 2 years after intracoronary administration of bone marrow-derived progenitor cells in acute myocardial infarction.

Authors:  Birgit Assmus; Andreas Rolf; Sandra Erbs; Albrecht Elsässer; Werner Haberbosch; Rainer Hambrecht; Harald Tillmanns; Jiangtao Yu; Roberto Corti; Detlef G Mathey; Christian W Hamm; Tim Süselbeck; Torsten Tonn; Stefanie Dimmeler; Thorsten Dill; Andreas M Zeiher; Volker Schächinger
Journal:  Circ Heart Fail       Date:  2009-12-08       Impact factor: 8.790

Review 4.  Stem Cell Therapies in Cardiovascular Disease.

Authors:  Maia Terashvili; Zeljko J Bosnjak
Journal:  J Cardiothorac Vasc Anesth       Date:  2018-04-26       Impact factor: 2.628

5.  Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells.

Authors:  K A Jackson; S M Majka; H Wang; J Pocius; C J Hartley; M W Majesky; M L Entman; L H Michael; K K Hirschi; M A Goodell
Journal:  J Clin Invest       Date:  2001-06       Impact factor: 14.808

6.  Grafted skeletal myoblast sheets attenuate myocardial remodeling in pacing-induced canine heart failure model.

Authors:  Hiroki Hata; Goro Matsumiya; Shigeru Miyagawa; Haruhiko Kondoh; Naomasa Kawaguchi; Nariaki Matsuura; Tatsuya Shimizu; Teruo Okano; Hikaru Matsuda; Yoshiki Sawa
Journal:  J Thorac Cardiovasc Surg       Date:  2006-10       Impact factor: 5.209

7.  A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction.

Authors:  Joshua M Hare; Jay H Traverse; Timothy D Henry; Nabil Dib; Robert K Strumpf; Steven P Schulman; Gary Gerstenblith; Anthony N DeMaria; Ali E Denktas; Roger S Gammon; James B Hermiller; Mark A Reisman; Gary L Schaer; Warren Sherman
Journal:  J Am Coll Cardiol       Date:  2009-12-08       Impact factor: 24.094

8.  Human cardiac stem cells.

Authors:  Claudia Bearzi; Marcello Rota; Toru Hosoda; Jochen Tillmanns; Angelo Nascimbene; Antonella De Angelis; Saori Yasuzawa-Amano; Irina Trofimova; Robert W Siggins; Nicole Lecapitaine; Stefano Cascapera; Antonio P Beltrami; David A D'Alessandro; Elias Zias; Federico Quaini; Konrad Urbanek; Robert E Michler; Roberto Bolli; Jan Kajstura; Annarosa Leri; Piero Anversa
Journal:  Proc Natl Acad Sci U S A       Date:  2007-08-20       Impact factor: 11.205

9.  c-kit(+)AT2R(+) Bone Marrow Mononuclear Cell Subset Is a Superior Subset for Cardiac Protection after Myocardial Infarction.

Authors:  Mingjun Du; Sebastian Schmull; Wentian Zhang; Chenxi Wang; Feng Lian; Yao Chen; Song Xue
Journal:  Stem Cells Int       Date:  2016-06-27       Impact factor: 5.443

Review 10.  Cardiac Regeneration with Human Pluripotent Stem Cell-Derived Cardiomyocytes.

Authors:  Misun Park; Young Sup Yoon
Journal:  Korean Circ J       Date:  2018-11       Impact factor: 3.243

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.